P. A. Shore

发表

Persistence of reserpine action after the disappearance of drug from brain: effect on serotonin.

B. Brodie, S. Hess, P. A. Shore, 1956, The Journal of pharmacology and experimental therapeutics.

Effects of amphetamine and amfonelic acid on the disposition of striatal newly synthesized dopamine.

P. A. Shore, H. H. Miller, 1982, European journal of pharmacology.

EVIDENCE FOR RELEASE OF BRAIN AMINES BY RESERPINE IN PRESENCE OF MONOAMINE OXIDASE INHIBITORS: IMPLICATION OF MONOAMINE OXIDASE IN NOREPINEPHRINE METABOLISM IN BRAIN

B. Brodie, R. Kuntzman, P. A. Shore, 1960 .

In vivo monoamine oxidase inhibition by d-amphetamine.

D. Clarke, P. A. Shore, H. H. Miller, 1980, Biochemical pharmacology.

THE DOPAMINE NEURONAL STORAGE SYSTEM AND NON-AMPHETAMINE PSYCHOTOGENIC STIMULANTS: A MODEL FOR PSYCHOSIS

M. Sanghera, D. German, B. McMillen, 1979 .

INTERACTION OF MONOAMINE OXIDASE INHIBITORS WITH PHYSIOLOGICAL AND BIOCHEMICAL MECHANISMS IN BRAIN

B. Brodie, P. A. Shore, S. Spector, 1959, Annals of the New York Academy of Sciences.

Serotonin-releasing activity limited to Rauwolfia alkaloids with tranquilizing action.

P. A. Shore, A. Pletscher, B. Brodie, 1956, Science.

On the mechanism of action of reserpine: effect of reserpine on capacity of tissues to bind serotonin.

B. Brodie, R. Kuntzman, P. A. Shore, 1957, The Journal of pharmacology and experimental therapeutics.

Dopaminergic neuronal responses to a non-amphetamine CNS stimulant

M. Sanghera, D. German, P. A. Shore, 2005, Journal of Neural Transmission.

Effects of Zoxazolamine and Related Centrally Acting Muscle Relaxants on Nigrostriatal Dopaminergic Neurons

M. Sanghera, D. German, S. Speciale, 1984, Brain Research Bulletin.

Functional and pharmacological significance of brain dopamine and norepinephrine storage pools.

D. German, B. McMillen, P. A. Shore, 1980, Biochemical pharmacology.

DIFFERENTIAL ACTIONS OF AMPHETAMINE ISOMERS ON A9 AND A10 DOPAMINE NEURONS: CORRELATION WITH PSYCHOTOGENIC EFFECTS

D. German, P. A. Shore, R. S. Kiser, 1979 .

Differences in norepinephrine and dopamine neurotransmitter storage systems

M. Sanghera, D. German, P. A. Shore, 1979, Brain Research Bulletin.

Release of serotonin from blood platelets by reserpine in vitro.

A. Carlsson, B. Brodie, P. A. Shore, 1957, The Journal of pharmacology and experimental therapeutics.

Actions of amfonelic acid and other non‐amphetamine stimulants on the dopamine neuron *

P. A. Shore, 1976, The Journal of pharmacy and pharmacology.

Absorption of drugs from the stomach. I. The rat.

B. Brodie, P. A. Shore, L. Schanker, 1957, The Journal of pharmacology and experimental therapeutics.

Biochemical and pharmacological studies of RO 1-9569 (tetrabenazine), a nonindole tranquilizing agent with reserpine-like effects.

B. Brodie, P. A. Shore, G. Quinn, 1959, The Journal of pharmacology and experimental therapeutics.

ANTICONVULSANT PROPERTIES OF MONOAMINE OXIDASE INHIBITORS

B. Brodie, D. Prockop, P. A. Shore, 1959, Annals of the New York Academy of Sciences.

Ascorbic acid in aromatic hydroxylation. II. Products formed by reaction of substrates with ascorbic acid, ferrous ion, and oxygen.

B. Brodie, J. Axelrod, S. Udenfriend, 1954, The Journal of biological chemistry.

Serotonin storage mechanism and its interaction with reserpine

B. Brodie, P. A. Shore, F. Hughes, 1958, Experientia.

Interaction of reserpine, serotonin, and lysergic acid diethylamide in brain.

B. Brodie, P. A. Shore, S. Silver, 1955, Science.

Distribution of Norepinephrine in the Heart

H. Maling, P. A. Shore, V. H. Cohn, 1958, Nature.

BINDING AND RELEASE OF METARAMINOL: MECHANISM OF NOREPINEPHRINE DEPLETION BY ALPHA-METHYL-M-TYROSINE AND RELATED AGENTS.

P. A. Shore, D. Busfield, H. Alpers, 1964, The Journal of pharmacology and experimental therapeutics.

Comparative effects of clozapine and alpha-adrenoceptor blocking drugs on regional noradrenaline metabolism in rat brain.

B. McMillen, P. A. Shore, 1978, European journal of pharmacology.

Effects of chronic desipramine treatment on rat brain noradrenergic responses to alpha-adrenergic drugs.

D. German, B. McMillen, P. A. Shore, 1980, European journal of pharmacology.

Role of dopamine storage function in the control of rat striatal tyrosine hydroxylase activity

B. McMillen, P. A. Shore, Brian A. McMillen, 1980, Naunyn-Schmiedeberg's Archives of Pharmacology.

On the mode of amine uptake by the Auerbach plexus of guinea pig small intestine.

P. A. Shore, M. F. Sugrue, 1971, European journal of pharmacology.

A kinetic analysis of drugs that inhibit the adrenergic neuronal membrane amine pump.

P. A. Shore, F. Berti, 1967, Biochemical pharmacology.

Fluorometric estimation of meteraminol and related compounds

P. A. Shore, H. Alpers, 1964 .

On the inability to produce supersensitivity to catecholamines in intestinal smooth muscle.

P. A. Shore, M. F. Sugrue, W. C. Govier, 1969, The Journal of pharmacology and experimental therapeutics.

ROLE OF BRAIN SEROTONIN IN RESERPINE ACTION

A. Carlsson, B. Brodie, R. Kuntzman, 1957, Annals of the New York Academy of Sciences.

[259] Fluorometric assay of histamine☆

P. A. Shore, 1971 .

Interaction of drugs with norepinephrine in the brain.

B. Brodie, P. A. Shore, S. Spector, 1959, Pharmacological reviews.

Effect of iproniazid on brain levels of norepinephrine and serotonin.

B. Brodie, P. A. Shore, Parkhurst A. Shore, 1958, Science.

ON THE MECHANISM OF ACTION OF CLOZAPINE ON THE ADRENERGIC NEURONE

P. A. Shore, R. Dorris, 1976, British journal of pharmacology.

Evidence for a prime role of newly synthesized dopamine in mesolimbic dopamine areas *

P. A. Shore, E. S. Sears, 1975, The Journal of pharmacy and pharmacology.

Release of Metaraminol (Aramine) from the Heart by Sympathetic Nerve Stimulation

E. Tatum, P. A. Shore, J. Crout, 1964, Science.

Failure to affect tissue reserpine concentrations by alteration of adrenergic nerve activity.

P. A. Shore, S. Norn, 1971, Biochemical Pharmacology.

Further studies on the nature of persistent reserpine binding: evidence for reversible and irreversible binding.

P. A. Shore, S. Norn, 1971, Biochemical Pharmacology.

On the physiological disposition and possible mechanism of the antihypertensive action of debrisoquin.

P. A. Shore, A. Giachetti, M. Medina, 1969, Biochemical pharmacology.

A method for the fluorometric assay of histamine in tissues.

P. A. Shore, P A SHORE, A BURKHALTER, 1959, The Journal of pharmacology and experimental therapeutics.

The relative functional availability of brain noradrenaline and dopamine storage pools *

B. McMillen, P. A. Shore, 1977, The Journal of pharmacy and pharmacology.

The mechanism of norepinephrine depletion by reserpine, metaraminol and related agents. The role of monoamine oxidase.

P. A. Shore, 1966, Pharmacological reviews.

Possible interrelationship between release of brain norepinephrine and serotonin by reserpine.

B. Brodie, R. Kuntzman, P. A. Shore, 1957, Science.

Localization and binding of reserpine in the membrane of adrenomedullary amine storage granules

P. A. Shore, A. Giachetti, R. Hollenbeck, 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

Transport and storage of biogenic amines.

P. A. Shore, 1972, Annual review of pharmacology.

Specific binding of reserpine. Association with norepinephrine depletion.

P. A. Shore, H. Alpers, 1969, Biochemical pharmacology.

Release of serotonin and catecholamines by drugs.

P. A. Shore, 1962, Pharmacological reviews.

Release of blood platelet serotonin by reserpine and lack of effect on bleeding time.

B. Brodie, R. Kuntzman, P. A. Shore, 1956, The Journal of pharmacology and experimental therapeutics.

On the formation of adrenergic amine storage granules as measured by reserpine labeling

P. A. Shore, A. Giachetti, 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

The reserpine receptor.

P. A. Shore, A. Giachetti, 1978, Life sciences.

Reserpine: Basic and Clinical Pharmacology

P. A. Shore, A. Giachetti, Parkhurst A. Shore, 1978 .

Identification and chemical assay of norepinephrine in brain and other tissues.

P. A. Shore, J. Olin, 1958, The Journal of pharmacology and experimental therapeutics.

Regional distribution of persistently bound reserpine in rat brain.

S. Enna, P. A. Shore, 1971, Biochemical pharmacology.

Serotonin as a mediator of reserpine action in brain.

B. Brodie, P. A. Shore, A. Pletscher, 1956, The Journal of pharmacology and experimental therapeutics.

Evidence that serotonin has a role in brain function.

B. Brodie, P. A. Shore, A. Pletscher, 1955, Science.

Serotonin release as a possible mechanism of reserpine action.

B. Brodie, P. A. Shore, A. Pletscher, 1955, Science.

MICROANALYTICAL PROCEDURES FOR FLUORO‐METRIC ASSAY OF BRAIN DOPA‐5HTP DECARBOXYLASE, NOREPINEPHRINE AND SEROTONIN, AND A DETAILED MAPPING OF DECARBOXYLASE ACTIVITY IN BRAIN

R. Kuntzman, P. A. Shore, D. Bogdanski, 1961, Journal of neurochemistry.

The gastric secretion of drugs: a pH partition hypothesis.

B. Brodie, P. A. Shore, B B BRODIE, 1957, The Journal of pharmacology and experimental therapeutics.

Effects of severe dopamine depletion on dopamine neuronal impulse flow and on tyrosine hydroxylase regulation

M. Sanghera, D. German, S. Saffer, 1981, Brain Research Bulletin.

Association between biochemical and behavioral actions of tricyclic antidepressants.

P. A. Shore, J. Murad, 1966, International journal of neuropharmacology.

Electrophysiological and biochemical responses of noradrenergic neurons to a non-amphetamine CNS stimulant

M. Sanghera, D. German, B. McMillen, 1979, Brain Research.

A CONCEPT FOR A ROLE OF SEROTONIN AND NOREPINEPHRINE AS CHEMICAL MEDIATORS IN THE BRAIN

B. Brodie, P. A. Shore, Bernard B. Brodie, 1957, Annals of the New York Academy of Sciences.

THE EFFECT OF DESMETHYLIMIPRAMINE ON RESERPINE AND INSULIN-INDUCED RELEASE OF GASTRIC HISTAMINE AND ADRENAL CATECHOLAMINES.

P. A. Shore, D. Busfield, 1964, Life sciences.

Comparative effects of monoamine oxidase inhibitors on monoamine oxidase and diamine oxidase.

P. A. Shore, V. H. Cohn, 1960, Biochemical pharmacology.

The mode of potassium action on the adrenergic neuron amine transport system.

P. A. Shore, M. F. Sugrue, 1969, Life sciences.

Optical specificity of monoamine oxidase.

P. A. Shore, A. Giachetti, 1966, Life sciences.

Studies in vitro of amine uptake mechanisms in heart.

P. A. Shore, A. Giachetti, 1966, Biochemical pharmacology.

Biochemical and pharmacological effects of the monoamine oxidase inhibitors, iproniazid, 1-phenyl-2-hydrazinopropane (JB 516) and 1-phenyl-3-hydrazinobutane (JB 835).

B. Brodie, P. A. Shore, S. Spector, 1960, The Journal of pharmacology and experimental therapeutics.

On the physiologic significance of monoamine oxidase in brain.

B. Brodie, R. Kuntzman, P. A. Shore, 1957, Science.

The chemical determination of histamine.

P. A. Shore, 1971, Methods of biochemical analysis.

Amine uptake and storage mechanisms in the corpus striatum of rat and rabbit.

P. A. Shore, R. Dorris, 1971, The Journal of pharmacology and experimental therapeutics.

Sex difference in histamine metabolism in the rat.

K. Netter, P. A. Shore, V. H. Cohn, 1961, The American journal of physiology.

Serotonin changes in platelets and brain induced by small daily doses of reserpine; lack of effect of depletion of platelet serotonin on hemostatic mechanisms.

B. Brodie, T. Dutcher, P. A. Shore, 1957, The New England journal of medicine.

Interaction of reserpine and ouabain on amine concentrating mechanisms in the adrenergic neurone.

P. A. Shore, F. Berti, 1967, Biochemical pharmacology.

Dual actions of guanethidine on amine uptake mechanisms in adrenergic neurons.

P. A. Shore, A. Giachetti, 1966, Biochemical pharmacology.

Release of rabbit platelet histamine by serum in vitro.

P. A. Shore, M. E. Tidball, 1962, American Journal of Physiology.

Antigen-induced histamine release from blood cells and acceleration of blood coagulation: Inhibition by tame

P. A. Shore, M. E. Tidball, H. Alpers, 1962 .

Midbrain dopamine neurons: differential responses to amphetamine isomers

D. German, P. A. Shore, S. Browder, 1981, Brain Research.

Biochemical Effects of Drugs

P. A. Shore, A. Burns, 1961 .

Amfonelic acid, a non‐amphetamine stimulant, has marked effects on brain dopamine metabolism but not noradrenaline metabolism: association with differences in neuronal storage systems *

B. McMillen, P. A. Shore, 1978, The Journal of pharmacy and pharmacology.

Species-Dependent Responsiveness to Nonamphetamine Central Stimulants

B. McMillen, P. A. Shore, 1979 .

An interpretation of the action of psychotropic drugs.

B. Brodie, D. Prockop, P. A. Shore, 1958, Postgraduate medicine.

The Neurobiology of Slow Synaptic Transmission

A. Carlsson, B. Brodie, P. A. Shore, 2001 .

On a prime role for newly synthesized dopamine in striatal function.

P. A. Shore, R. Dorris, 1975, European journal of pharmacology.

MECHANISM OF ACTION OF RESERPINE AND INSULIN ON GASTRIC AMINES AND GASTRIC ACID SECRETION, AND THE EFFECT OF MONOAMINE OXIDASE INHIBITION.

P. A. Shore, K. S. Kim, 1963, The Journal of pharmacology and experimental therapeutics.

Distribution of clozapine in the rat: localization in lung.

P. A. Shore, T. Gardiner, J. Lewis, 1978, The Journal of pharmacology and experimental therapeutics.

X-Ray Dose Determinations with Chloral Hydrate

H. L. Andrews, P. A. Shore, 1950 .

Characteristics of storage and release of metaraminol in the rat heart.

S. Enna, P. A. Shore, 1972, Biochemical pharmacology.

Potentiating Action of Chlorpromazine and Reserpine

B. Brodie, P. A. Shore, BERNARD B. BRODIE, 1955, Nature.

EFFECT OF 1-PHENYL-2-HYDRAZINOPROPANE, A POTENT MONOAMINE OXIDASE (MAO) INHIBITOR, ON BRAIN LEVELS OF NOREPINEPHRINE AND SEROTONIN

B. Brodie, P. A. Shore, S. Spector, 1958 .

A simple technique involving solvent extraction for the estimation of norepinephrine and epinephrine in tissues.

P. A. Shore, 1959, Pharmacological reviews.

On the nature of the adrenergic neuron extragranular amine binding site

S. Enna, P. A. Shore, 2005, Journal of Neural Transmission.

On a Role for Serotonin and Norepinephrine as Chemical Mediators in the Central Autonomic Nervous System

B. Brodie, P. A. Shore, 1957 .

Release of histamine from stomach by vagus-stimulating drugs: association with gastric acid secretion.

P. A. Shore, 1965, Federation proceedings.

Reserpine: A Survey of Its Pharmacology

P. A. Shore, 1971 .

Advances in pharmacology

S. Garattini, P. A. Shore, T. August, 1962 .

Interaction of serotonin and lysergic acid diethylamide (LSD) in the central nervous system

B. Brodie, P. A. Shore, S. L. Silver, 1955, Experientia.

ON THE MECHANISM OF NOREPINEPHRINE DEPLETION BY RESERPINE, METARAMINOL AND RELATED COMPOUNDS AND ANTAGONISM BY MONOAMINE OXIDASE INHIBITION

P. A. Shore, D. Busfield, H. Alpers, 1966 .

Specific inhibition by -methyltyrosine of amphetamine-induced amine release from brain.

S. Enna, P. A. Shore, R. Dorris, 1973, The Journal of pharmacology and experimental therapeutics.

LSD-Like Effects Elicited by Reserpine in Rabbits Pretreated With Iproniazid.∗

B. Brodie, P. A. Shore, 1957, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Permeability changes induced in the adrenergic neurone by reserpine.

P. A. Shore, A. Giachetti, 1970, Biochemical pharmacology.

Biochemistry of monoamine oxidase inhibitors

P. A. Shore, 1960 .

Effect of Iproniazid on Brain Levels of Norepinephrine and Serotonin

B. Brodie, P. A. Shore, S. Spector, 1958, Science.

Rapid biosynthesis of brain serotonin before and after reserpine administration

B. Brodie, R. Kuntzman, P. A. Shore, 2004, Die Naturwissenschaften.

Chemistry of Drug Metabolism

P. A. Shore, 1961 .

Effect of reserpine, serotonin, and 5-hydroxytryptophan on rabbit platelet histamine in vivo and in vitro.

P. A. Shore, V. H. Cohn, A. Burkhalter, 1960, Biochemical pharmacology.

Platelet Damage induced in Plasma by Certain Fatty Acids

P. A. Shore, H. Alpers, P. A. SHORE, 1963, Nature.

Pimozide: delayed onset of action at rat striatal pre- and postsynaptic dopamine receptors.

D. German, B. McMillen, P. A. Shore, 1980, The Journal of pharmacology and experimental therapeutics.

On the Reported Inhibition of Monoamine Oxidase by an Agent with Sedative Properties

B. Brodie, P. A. Shore, S. Spector, 1960, Science.

Observations on the fate of dromoran in the dog and its secretion into the gastric juice.

B. Brodie, J. Axelrod, P. A. Shore, 1955, Journal of Pharmacology and Experimental Therapeutics.

Monoamine oxidase inhibition in the adrenergic neuron by bretylium, debrisoquin, and other adrenergic neuronal blocking agents

P. A. Shore, A. Giachetti, 1967 .

A microfluorometric method for the determination of agmatine.

P. A. Shore, V. H. Cohn, 1961, Analytical biochemistry.

Midbrain dopamine neurons: differential responses to amphetamine isomers

D. German, P. A. Shore, S. Browder, 1981, Brain Research.

Localization and persistence of metaraminol and -methyl-m-tyramine in rat and rabbit brain.

P. A. Shore, R. Dorris, 1971, The Journal of pharmacology and experimental therapeutics.

Increased sensitivity in a specific fluorometric method for brain histamine.

P. A. Shore, M. Medina, 1966, Biochemical pharmacology.

Interaction of apomorphine, neuroleptics and stimulants with alpha-methyl-m-tyramine, a false dopaminergic transmitter.

P. A. Shore, R. Dorris, 1974, Biochemical Pharmacology.

Evidence for α‐methyl‐m‐tyramine as a false dopamine‐like transmitter

P. A. Shore, R. Dorris, 1972 .